Rapid Micro Biosystems RPID
NASDAQ RPID
$1.68 +0.01 (+0.60%)
At close: Aug 21, 2026 · 4:00 PM EDT

Rapid Micro Biosystems (RPID) Income towards Parent Company (2020 - 2026)

Rapid Micro Biosystems (RPID) posted Income towards Parent Company of -$14.3 million for Q1 2026, down 14.23% sequentially from -$12.5 million in Q4 2025, and down 26.74% YoY from -$19.5 million in Q1 2025.

Rapid Micro Biosystems (RPID) Income towards Parent Company (2020 - 2026) Analysis & Trends

Rapid Micro Biosystems has reported Income towards Parent Company for 7 years, with the latest figure at -$14.3 million in Q1 2026.

  • Quarterly Income towards Parent Company fell 26.74% year-over-year to -$14.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$50.1 million (down 11.83% YoY) and the FY2025 annual result came in at -$47.1 million, changed 0.5% from the prior year.
  • Income towards Parent Company eased to -$14.3 million in Q1 2026 per RPID's latest filing, from -$12.5 million in the prior quarter.
  • Over five years, Income towards Parent Company peaked at -$9.7 million in Q4 2024 and troughed at -$16.5 million in Q4 2022.
  • A 5-year average of -$13.0 million and a median of -$13.1 million in 2022 frame the typical range for Income towards Parent Company.
  • The sharpest annual moves came in 2022 and 2025: Income towards Parent Company soared 34.61% in 2022, then slipped 29.29% in 2025.
  • Over 5 years, Income towards Parent Company stood at -$16.5 million in 2022, then jumped by 32.14% to -$11.2 million in 2023, then rose by 13.48% to -$9.7 million in 2024, then slipped by 29.29% to -$12.5 million in 2025, then slipped by 14.23% to -$14.3 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$14.3 million, -$12.5 million, and -$11.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 202.72 Bn 197.12 Bn 7.27 Bn
2 Stryker 126.42 Bn 122.94 Bn 4.50 Bn
3 Medtronic 119.75 Bn 110.53 Bn 6.41 Bn
4 Boston Scientific 74.13 Bn 73.60 Bn 3.85 Bn
5 Edwards Lifesciences 51.78 Bn 47.53 Bn 1.35 Bn
6 Dexcom 35.29 Bn 33.34 Bn 830.00 Mn
7 GE HealthCare Technologies 33.95 Bn 31.85 Bn 2.18 Bn
8 Koninklijke Philips 26.22 Bn 22.90 Bn 4.55 Bn
9 Steris 23.21 Bn 22.73 Bn 684.20 Mn
10 Rapid Micro Biosystems 80.26 Mn 60.49 Mn 1.21 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -12.92 Mn
Mar 31, 2026 -14.28 Mn
Dec 31, 2025 -12.50 Mn
Sep 30, 2025 -11.51 Mn
Jun 30, 2025 -11.86 Mn
Mar 31, 2025 -11.26 Mn
Dec 31, 2024 -9.67 Mn
Sep 30, 2024 -11.32 Mn
Jun 30, 2024 -12.58 Mn
Mar 31, 2024 -13.32 Mn
Dec 31, 2023 -11.17 Mn
Sep 30, 2023 -13.39 Mn
Jun 30, 2023 -14.02 Mn
Mar 31, 2023 -13.89 Mn
Dec 31, 2022 -16.46 Mn
Sep 30, 2022 -16.34 Mn
Jun 30, 2022 -13.10 Mn
Mar 31, 2022 -14.93 Mn
Dec 31, 2021 -14.61 Mn
Sep 30, 2021 -24.99 Mn